Nu Skin Enterprises, Inc. with ticker code (NUS) have now 4 analysts covering the stock with the consensus suggesting a rating of ‘Hold’. The range between the high target price and low target price is between 43 and 35 with the average target price sitting at 38.75. Now with the previous closing price of 41.46 this would imply there is a potential downside of -6.5%. The 50 day MA is 42.44 and the 200 day moving average is 41.54. The company has a market cap of $2,044m. Visit the company website at: https://www.nuskin.com
The potential market cap would be $1,910m based on the market concensus.
Nu Skin Enterprises, Inc., together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products. The company also provides wellness products, such as ageLOC Meta, LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+. In addition, it is involved in the research and product development of skin care products and nutritional supplements. The company sells its products under the Nu Skin, Pharmanex, and ageLOC brands through retail stores, website, digital platforms, and independent direct sellers and marketers, as well as a service center. Nu Skin Enterprises, Inc. was founded in 1984 and is headquartered in Provo, Utah.
